Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Fendly

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1993
Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptorL A Tartaglia, D V Goeddel, C Reynolds, et al.
Cancer Research|March 15, 1996
Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsivenessG D Lewis, J A Lofgren, A E McMurtrey, et al.
Hybridoma|August 1, 1987
Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factorB M Fendly, K J Toy, A A Creasey, et al.
Biochemistry|February 4, 1992
Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregationD Pennica, W J Kohr, B M Fendly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1993
Humanization of an antibody directed against IgEL G Presta, S J Lahr, R L Shields, et al.
The Journal of Biological Chemistry|October 15, 1992
Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylationD Pennica, V T Lam, N K Mize, et al.
Growth Regulation|June 1, 1991
Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growthJ C Sarup, R M Johnson, K L King, et al.
Journal of Clinical Pathology|August 1, 1992
HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodiesA H Arnaout, P M Dawson, S Soomro, et al.
Journal of Biological Response Modifiers|October 1, 1990
The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancerB M Fendly, C Kotts, D Vetterlein, et al.
AIDS Research and Human Retroviruses|November 1, 1992
Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolatesG R Nakamura, R Byrn, K Rosenthal, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1993
Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptorL A Tartaglia, D V Goeddel, C Reynolds, et al.
Cancer Research|March 15, 1996
Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsivenessG D Lewis, J A Lofgren, A E McMurtrey, et al.
Hybridoma|August 1, 1987
Murine monoclonal antibodies defining neutralizing epitopes on tumor necrosis factorB M Fendly, K J Toy, A A Creasey, et al.
Biochemistry|February 4, 1992
Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregationD Pennica, W J Kohr, B M Fendly, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1993
Humanization of an antibody directed against IgEL G Presta, S J Lahr, R L Shields, et al.
The Journal of Biological Chemistry|October 15, 1992
Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylationD Pennica, V T Lam, N K Mize, et al.
Growth Regulation|June 1, 1991
Characterization of an anti-p185HER2 monoclonal antibody that stimulates receptor function and inhibits tumor cell growthJ C Sarup, R M Johnson, K L King, et al.
Journal of Clinical Pathology|August 1, 1992
HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodiesA H Arnaout, P M Dawson, S Soomro, et al.
Journal of Biological Response Modifiers|October 1, 1990
The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancerB M Fendly, C Kotts, D Vetterlein, et al.
AIDS Research and Human Retroviruses|November 1, 1992
Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolatesG R Nakamura, R Byrn, K Rosenthal, et al.
Pageof 5